• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

0.2383 -0.0195 (-7.56%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 146,682
Open 0.2635
Bid (Size) 0.2350 (900)
Ask (Size) 0.2382 (400)
Prev. Close 0.2578
Today's Range 0.2300 - 0.2635
52wk Range 0.2260 - 15.75
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
October 06, 2026
Via Chartmill
News headline image
GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026
October 06, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

52-Week Range 98.5% below 52-week high
0.2383
0.2352W Low 15.7552W High
1 Week 20.6% below 1-week high
0.231W Low 0.301W High

GeoVax Labs, Inc. - Common Stock (GOVX) traded between $0.23 and $15.75 over the past 52 weeks and last traded at $0.24, 98.5% below its 52-week high. Over the past week it ranged between $0.23 and $0.30.

Past 12 Months
-15.6%
-41.2%
-75.5%
-80.8%
-95.4%
-98.3%
1W -$0.04
1M -$0.17
3M -$0.74
6M -$1.00
YTD -$4.94
1Y -$13.81

GOVX was -98.3% over the past year, -80.8% over six months, -95.4% year to date, -15.6% in the last week.

12 Months vs Market
GOVX
-98.3%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months GOVX returned -98.3% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.19× 3-mo avg
Today 146,682 3-mo avg 761.9K
1W
379.1K
1M
840.4K
3M
761.9K
6M
2.9M
YTD
1.9M
1Y
1.5M

GOVX most recently traded 146,682 shares against a 3-month average daily volume of 761.9K.

More News

Read More
What's going on in today's pre-market session ↗
October 06, 2026
Via Chartmill
These stocks are moving in today's after hours session ↗
October 05, 2026
Via Chartmill
GeoVax Labs (GOVX): High Growth Stock Beats Earnings, Advances Mpox Vaccine and Cancer Therapy ↗
July 27, 2026
Via Chartmill
News headline image
GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United States
September 29, 2026
Via NewMediaWire
News headline image
GeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical Models
September 21, 2026
Via NewMediaWire
News headline image
GeoVax Confirms Bundibugyo Ebola Vaccine Construct
September 16, 2026
Via NewMediaWire
News headline image
GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial
September 14, 2026
Via NewMediaWire
News headline image
GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities
September 10, 2026
Via NewMediaWire
News headline image
GeoVax Welcomes Launch of Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness to Support Diversified Global Supply
September 09, 2026
Via NewMediaWire
Wondering what's happening in today's after-hours session? ↗
August 28, 2026
Via Chartmill
News headline image
GeoVax Announces a Warrant Inducement Transaction
August 26, 2026
Via NewMediaWire
News headline image
GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation
August 25, 2026
Via NewMediaWire
The trading volume of these stocks is deviating from the norm in today's session. ↗
August 24, 2026
Via Chartmill
News headline image
GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak
August 24, 2026
Via NewMediaWire
News headline image
GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies
August 24, 2026
Via NewMediaWire
News headline image
GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit
August 20, 2026
Via NewMediaWire
News headline image
GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak
August 13, 2026
Via NewMediaWire
Topics Death
News headline image
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase
August 11, 2026
Via NewMediaWire
News headline image
GeoVax Announces Completion of Key GEO-MVA Development Milestones, Positioning Program for Pivotal Phase 3 Clinical Study
August 06, 2026
Via NewMediaWire
News headline image
GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio
August 03, 2026
Via NewMediaWire
News headline image
GeoVax Reports Second Quarter 2026 Financial Results and Provides Business Update
July 27, 2026
Via NewMediaWire
News headline image
GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy
July 21, 2026
Via NewMediaWire
News headline image
GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
July 01, 2026
Via NewMediaWire
Topics Economy

Frequently Asked Questions

Is GeoVax Labs, Inc. - Common Stock publicly traded?
Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
What exchange does GeoVax Labs, Inc. - Common Stock trade on?
GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
What is the current price of GeoVax Labs, Inc. - Common Stock?
The current price of GeoVax Labs, Inc. - Common Stock is 0.2383
When was GeoVax Labs, Inc. - Common Stock last traded?
The last trade of GeoVax Labs, Inc. - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
The market capitalization of GeoVax Labs, Inc. - Common Stock is 517.66K
How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
GeoVax Labs, Inc. - Common Stock has 518K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap